|
131 |
Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study
Enthalten in BMC neurology Bd. 12, 6.3.2012, Nr. 1, date:12.2012: 1-13
|
|
|
|
132 |
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
Enthalten in Nature Communications Bd. 13, 15.6.2022, Nr. 1, date:12.2022: 1-15
|
|
|
|
133 |
Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials
Enthalten in BMC medicine Bd. 19, 6.12.2021, Nr. 1, date:12.2021: 1-15
|
|
|
|
134 |
Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade
Enthalten in Journal of translational medicine Bd. 22, 5.3.2024, Nr. 1, date:12.2024: 1-12
|
|
|
|
135 |
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
Enthalten in Communications biology Bd. 5, 6.10.2022, Nr. 1, date:12.2022: 1-15
|
|
|
|
136 |
Correction to: Harmonised projections of future forest resources in Europe
Enthalten in Annals of forest science Bd. 76, 3.9.2019, Nr. 3, date:9.2019: 1-2
|
|
|
|
137 |
“De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade
Enthalten in Acta neuropathologica Bd. 147, 11.12.2023, Nr. 1, date:6.2024: 1-24
|
|
|
|
138 |
De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome
Enthalten in Nature Bd. 632, 11.7.2024, Nr. 8026, date:8.2024: 832-840
|
|
|
|
139 |
Deciphering the role of histone modifications in memory and exhausted CD8 T cells
Enthalten in Scientific reports Bd. 15, 19.5.2025, Nr. 1, date:12.2025: 1-22
|
|
|
|
140 |
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Enthalten in Nature Bd. 558, 30.5.2018, Nr. 7709, date:6.2018: 307-312
|
|
Administration
